Evidence map›Paper›PMID 32823764›Full record

ReviewCells2020

Involvement of JNK1 in Neuronal Polarization During Brain Development.

Rubén Darío Castro-Torres, Oriol Busquets, Antoni Parcerisas, Ester Verdaguer, Jordi Olloquequi, Miren Ettcheto, Carlos Beas-Zarate, Jaume Folch, Antoni Camins, Carme Auladell

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. medRxiv : the preprint server for health sciences · 2025
    Article
  5. Article
  6. The role of JNK signaling pathway in organ fibrosis.Journal of advanced research · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. DualInternational journal of molecular sciences · 2021
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Rubén Darío Castro-TorresDepartment of Cell and Molecular Biology, Laboratory of Biology of Neurotransmission, C.U.C.B.A., Universidad de Guadalajara, 45200 Jalisco, Mexico.ORCID 0000-0003-3334-3096
Oriol BusquetsDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacy and Food Sciences Faculty, Universitat de Barcelona, 08028 Barcelona, Spain.ORCID 0000-0002-1372-9699
Antoni ParcerisasCentre for Biomedical Research of Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Ester VerdaguerCentre for Biomedical Research of Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Jordi OlloquequiLaboratory of Cellular and Molecular Pathology, Biomedical Sciences Institute, Health Sciences Faculty, Universidad Autónoma de Chile, 3460000 Talca, Chile.ORCID 0000-0002-6492-2739
Miren EttchetoDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacy and Food Sciences Faculty, Universitat de Barcelona, 08028 Barcelona, Spain.ORCID 0000-0002-4301-7297
Carlos Beas-ZarateDepartment of Cell and Molecular Biology, Laboratory of Neural Regeneration, C.U.C.B.A., Universidad de Guadalajara, 44340 Jalisco, Mexico.
Jaume FolchDepartment of Biochemistry and Biotechnology, Medicine and Health Sciences Faculty, Universitat Rovira i Virgil, 43201 Reus, Spain.
Antoni CaminsDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacy and Food Sciences Faculty, Universitat de Barcelona, 08028 Barcelona, Spain.ORCID 0000-0002-1229-5956
Carme AuladellCentre for Biomedical Research of Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0001-8345-1859
Instituto de Salud Carlos III · ESUniversidad de Guadalajara · MXUniversidad Autónoma de Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The c-Jun N-terminal Kinases (JNKs) are a group of regulatory elements responsible for the control of a wide array of functions within the cell. In the central nervous system (CNS), JNKs are involved in neuronal polarization, starting from the cell division of neural stem cells and ending with their final positioning when migrating and maturing. This review will focus mostly on isoform JNK1, the foremost contributor of total JNK activity in the CNS. Throughout the text, research from multiple groups will be summarized and discussed in order to describe the involvement of the JNKs in the different steps of neuronal polarization. The data presented support the idea that isoform JNK1 is highly relevant to the regulation of many of the processes that occur in neuronal development in the CNS.

Indexed as

AnimalsBrainCell PolarityDoublecortin ProteinHumansIsoenzymesMiceMitogen-Activated Protein Kinase 8NeuronsPhosphorylationSignal TransductionDcx protein, mouseDoublecortin ProteinIsoenzymesMitogen-Activated Protein Kinase 8asymmetric divisionDCXJNK1MAP1BmigrationNMDARSCG10synaptogenesisWDR62

Identifiers

PMID32823764
PMCPMC7466125
OpenAlexW3048561969

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.